
GC69599
NT219
Also known as (E)-3-(2-bromo-3,4-dihydroxyphenyl)-N-[(3,4,5-trihydroxyphenyl)methyl]prop-2-enethioamide
NT219 is an effective dual inhibitor of insulin receptor substrate 1/2 (IRS1/2) and STAT3· IRS1/2 and STAT3 are major signaling pathways regulated by various oncogenes· NT219 affects the degradation of IRS1/2 and inhibits the phosphorylation of STAT3· NT219 has potential for researching cancer diseases
ChemicalCAS1198078-60-2MW412.26FormulaC16H14BrNO5S
- CAS number
- 1198078-60-2
- Molecular weight
- 412.26
- Formula
- C16H14BrNO5S
- Solubility
- DMSO : ≥ 100 mg/mL (242·57 mM)
- InChIKey
- XDDQKKXXQHUUHJ-DUXPYHPUSA-N
- Catalogue number
- GC69599
- Brand
- GLPBIO
Computed properties PubChem CID 135914977 · XLogP 2.6 · TPSA 145 Ų · H-bond donors 6
- XLogP
- 2.6
- TPSA
- 145 Ų
- H-bond donors
- 6
- H-bond acceptors
- 6
- Rotatable bonds
- 4
- Heavy atoms
- 24
SMILES C1=CC(=C(C(=C1/C=C/C(=S)NCC2=CC(=C(C(=C2)O)O)O)Br)O)O
Computed descriptors from PubChem (CID 135914977), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il